TY - JOUR
T1 - Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic Spread
AU - Marinari, Eliana
AU - Dutoit, Valerie
AU - Nikolaev, Sergey
AU - Vargas, Maria Isabel
AU - Schaller, Karl
AU - Lobrinus, Johannes Alexander
AU - Dietrich, Pierre Yves
AU - Tsantoulis, Petros
AU - Migliorini, Denis
N1 - Publisher Copyright:
© American Academy of Neurology.
PY - 2021/4/15
Y1 - 2021/4/15
N2 - ObjectiveHigh-grade glioma (HGG) rarely spreads outside the CNS. To test the hypothesis that the lesions were metastases originating from an HGG, we sequenced the relapsing HGG and distant extraneural lesions.MethodsWe performed whole-exome sequencing of an HGG lesion, its local relapse, and distant lesions in bone and lymph nodes.ResultsPhylogenetic reconstruction and histopathologic analysis confirmed the common glioma origin of the secondary lesions. The mutational profile revealed an IDH1/2 wild-type HGG with an activating mutation in EGFR and biallelic focal loss of CDKN2A (9p21). In the metastatic samples and the local relapse, we found an activating PIK3CA mutation, further copy number gains in chromosome 7 (EGFR), and a putative pathogenic driver mutation in a canonical splice site of FLNA.ConclusionsOur findings demonstrate tumor spread outside the CNS and identify potential genetic drivers of metastatic dissemination outside the CNS, which could be leveraged as therapeutic targets or potential biomarkers.
AB - ObjectiveHigh-grade glioma (HGG) rarely spreads outside the CNS. To test the hypothesis that the lesions were metastases originating from an HGG, we sequenced the relapsing HGG and distant extraneural lesions.MethodsWe performed whole-exome sequencing of an HGG lesion, its local relapse, and distant lesions in bone and lymph nodes.ResultsPhylogenetic reconstruction and histopathologic analysis confirmed the common glioma origin of the secondary lesions. The mutational profile revealed an IDH1/2 wild-type HGG with an activating mutation in EGFR and biallelic focal loss of CDKN2A (9p21). In the metastatic samples and the local relapse, we found an activating PIK3CA mutation, further copy number gains in chromosome 7 (EGFR), and a putative pathogenic driver mutation in a canonical splice site of FLNA.ConclusionsOur findings demonstrate tumor spread outside the CNS and identify potential genetic drivers of metastatic dissemination outside the CNS, which could be leveraged as therapeutic targets or potential biomarkers.
UR - http://www.scopus.com/inward/record.url?scp=85139950877&partnerID=8YFLogxK
U2 - 10.1212/NXG.0000000000000561
DO - 10.1212/NXG.0000000000000561
M3 - Article
AN - SCOPUS:85139950877
SN - 2376-7839
VL - 7
SP - e561
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 2
ER -